BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26518154)

  • 1. [Vaccination in the early post-partum: Guidelines].
    Doret M; Marcellin L
    J Gynecol Obstet Biol Reprod (Paris); 2015 Dec; 44(10):1135-40. PubMed ID: 26518154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-partum: Guidelines for clinical practice--Short text].
    Sénat MV; Sentilhes L; Battut A; Benhamou D; Bydlowski S; Chantry A; Deffieux X; Diers F; Doret M; Ducroux-Schouwey C; Fuchs F; Gascoin G; Lebot C; Marcellin L; Plu-Bureau G; Raccah-Tebeka B; Simon E; Bréart G; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2015 Dec; 44(10):1157-66. PubMed ID: 26527017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Sanftenberg L; Schrörs HJ; Schelling J
    Vaccine; 2016 Jul; 34(34):3938-41. PubMed ID: 27318420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination policies among health professional schools: evidence of immunity and allowance of vaccination exemptions.
    Dolan SB; Libby TE; Lindley MC; Ahmed F; Stevenson J; Strikas RA
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):186-91. PubMed ID: 25633001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-partum contraception: Guidelines for clinical practice].
    Raccah-Tebeka B; Plu-Bureau G
    J Gynecol Obstet Biol Reprod (Paris); 2015 Dec; 44(10):1127-34. PubMed ID: 26527021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination and pregnancy].
    Anselem O; Parat S; Théau A; Floret D; Tsatsaris V; Goffinet F; Launay O
    Presse Med; 2014 Jun; 43(6 Pt 1):715-21. PubMed ID: 24863661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult immunizations: update on recommendations.
    Pham H; Geraci SA; Burton MJ;
    Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
    Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations.
    Heijstek MW; Ott de Bruin LM; Borrow R; van der Klis F; Koné-Paut I; Fasth A; Minden K; Ravelli A; Abinun M; Pileggi G; Borte M; Bijl M; Wulffraat NM
    Autoimmun Rev; 2011 Dec; 11(2):112-22. PubMed ID: 21896342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of medical and paramedical university students in Lebanon against measles, mumps, rubella and varicella: active measures are needed.
    Chamat S; Salameh P; Haddad N; Berry A; Chedid P; Bouharoun-Tayoun H
    J Infect Public Health; 2011 Aug; 4(3):125-34. PubMed ID: 21843858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and Safety.
    Ma SJ; Li X; Xiong YQ; Yao AL; Chen Q
    Medicine (Baltimore); 2015 Nov; 94(44):e1721. PubMed ID: 26554769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.
    Marshall GS; Senders SD; Shepard J; Twiggs JD; Gardner J; Hille D; Hartzel J; Valenzuela R; Stek JE; Helmond FA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2188-2196. PubMed ID: 27149048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
    Maltezou HC; Tseroni M; Drositis I; Gamaletsou MN; Koukou DM; Bolikas E; Peskelidou E; Daflos C; Panagiotaki E; Ledda C; Pavli A; Moussas N; Kontogianni S; Svarna E; Ploumidis M; Spyrou A; Chini M; Adamis G; Lourida A; Hatzigeorgiou D; Gargalianos P; Syrogiannopoulos G; Sipsas NV
    Expert Rev Vaccines; 2022 Jun; 21(6):853-859. PubMed ID: 35382665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.